Gladstone Institutional Advisory’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Gladstone Institutional Advisory's EXEL Position: Q4 2025 in Review
Gladstone Institutional Advisory sold out of Exelixis (EXEL) in Q4 2025, closing a stake of 13,863 shares — an estimated $573K sold.
Gladstone Institutional Advisory first reported a position in EXEL in Q1 2025 and held it in 3 quarters. The position peaked at $606K in Q2 2025. 685 funds tracked by Wall St. Rank hold EXEL as of Q4 2025.
- Gladstone Institutional Advisory reported no remaining Exelixis position as of Q4 2025 after selling out during the quarter.
- Gladstone Institutional Advisory sold 13,863 Exelixis shares in Q4 2025, an estimated $573K.
- Gladstone Institutional Advisory first reported a position in Exelixis in Q1 2025 and held it in 3 quarters.
- Gladstone Institutional Advisory's Exelixis position peaked at $606K in Q2 2025.
- 685 funds tracked by Wall St. Rank held Exelixis as of Q4 2025.
Based on Gladstone Institutional Advisory's 13F filing for Q4 2025, filed 17 Feb 2026.